Medicare selects Botox and Trulicity among 15 high-cost drugs for price negotiations under new federal authority, with lower ...
The Trump administration has unveiled 15 new drugs selected for a Medicare drug price negotiation program that allows the ...
Negotiations Will Occur in 2026 With Negotiated Prices Effective in 2028.8, 2026 - On Tuesday, the Centers for Medicare & ...
President Donald Trump’s approach to lowering drug prices has leaned heavily on executive orders and voluntary deals with drugmakers, rather than legislation. (Andrew Harnik / Getty Images) As ...
As the Trump administration begins to make its mark on the Medicare drug price negotiation program and pursue its own policies on prescription drugs, litigation over program continues. In the two ...
A recent U.S. Court of Appeals for the Third Circuit ruling upholding the federal Inflation Reduction Act (IRA)’s drug price ...
A federal appellate court has handed down the first appellate-level decision addressing the merits of drug manufacturers’ challenges to the Inflation Reduction Act of 2022's (IRA) Medicare Drug ...
On May 12, 2025, the Centers for Medicare & Medicaid Services (CMS) issued draft guidance for the third cycle of the IRA’s Medicare Drug Price Negotiation Program (Negotiation Program). This draft ...
MyHighPlains on MSN
Botox, Trulicity among 15 drugs on new Medicare negotiations list
The selected medications treat a range of conditions, including cancer, psoriatic arthritis, and human immunodeficiency virus ...
As President Donald Trump touts new deals to cut the cost of blockbuster drugs like Wegovy and Zepbound, he’s barely mentioned Medicare’s drug price negotiation program — even though the government is ...
As President Donald Trump touts new deals to cut the cost of blockbuster drugs like Wegovy and Zepbound, he’s barely mentioned Medicare’s drug price negotiation program — even though the government is ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results